Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 39, 2021 - Issue 13
Journal homepage
5,189
Views
72
CrossRef citations to date
0
Altmetric
Research Articles

Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

Mubarak A. Alamria Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkarj, Saudi Arabia
,
Muhammad Tahir ul Qamarb College of Life Science and Technology, Guangxi University, Nanning, P. R. ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-4832-4250
ORCID Icon,
Muhammad Usman Mirzac Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, Medicinal Chemistry, University of Leuven, Leuven, BelgiumORCID Iconhttps://orcid.org/0000-0001-9120-2414
ORCID Icon,
Rajendra Bhadaned Structural Bioinformatics Laboratory, Faculty of Science and Engineering, Biochemistry, Åbo Akademi University, Turku, Finland;e Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Pharmacy, Åbo Akademi University, Turku, Finland
,
Safar M. Alqahtania Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkarj, Saudi Arabia
,
Iqra Muneerf School of Life Sciences, University of Science and Technology of China, Hefei, P. R. China
,
Matheus Froeyenc Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, Medicinal Chemistry, University of Leuven, Leuven, Belgium
&
Outi M. H. Salo-Ahend Structural Bioinformatics Laboratory, Faculty of Science and Engineering, Biochemistry, Åbo Akademi University, Turku, Finland;e Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Pharmacy, Åbo Akademi University, Turku, FinlandCorrespondence[email protected] [email protected]
 show all
Pages 4936-4948 | Received 27 Feb 2020, Accepted 08 Jun 2020, Published online: 24 Jun 2020

Citations (72)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (22)

Sadek Ahmed, Maha M. Amin & Sinar Sayed. (2023) A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration. Drug Delivery 30:1.
Read now
Alaa Karkashan & Roba Attar. (2023) Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell. Journal of Biomolecular Structure and Dynamics 41:19, pages 9987-9996.
Read now
Aweke Mulu Belachew, Rakesh Kumar Bachheti, Araya Kahsay Weldekidan & Mulugeta Gajaa Ufgaa. (2023) Computational prediction and analysis of targeting 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD1) with natural products for colorectal cancer treatment. Journal of Biomolecular Structure and Dynamics 41:16, pages 7966-7974.
Read now
Priyanka Purohit, Madhusmita Panda, Jules Tshishimbi Muya, Pradipta Bandyopadhyay & Biswa Ranjan Meher. (2023) Theoretical insights into the binding interaction of Nirmatrelvir with SARS-CoV-2 Mpro mutants (C145A and C145S): MD simulations and binding free-energy calculation to understand drug resistance. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now
Muhammad Zubair, Sidra Khalil, Ijaz Rasul, Habibullah Nadeem, Fatima Noor, Sajjad Ahmad, Faris Alrumaihi, Khaled S. Allemailem, Ahmad Almatroudi, Faez Falah Alshehri & Zafer Saad Alshehri. (2023) Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-15.
Read now
Hanuman Singh Dagur, Esmaeil Behmard, Eerappa Rajakumara & Ebrahim Barzegari. (2023) Identifying potent inhibitory phytocompounds from Lagerstroemia speciosa against SARS-Coronavirus-2: structure-based virtual screening. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Abhishek Saini, Amit Kumar, Kailash Jangid, Vinod Kumar & Vikas Jaitak. (2023) Identification of terpenoids as dihydropteroate synthase and dihydrofolate reductase inhibitors through structure-based virtual screening and molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Rowida Omar, Mohamed Abd El-Salam, Marwa Elsbaey & Madiha Hassan. (2023) Fourteen immunomodulatory alkaloids and two prenylated phenylpropanoids with dual therapeutic approach for COVID-19: molecular docking and dynamics studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Yasir Bashir, Fatima Noor, Sajjad Ahmad, Muhammad Hamza Tariq, Muhammad Qasim, Muhammad Tahir ul Qamar, Ahmad Almatroudi, Khaled S. Allemailem, Faris Alrumaihi & Faez Falah Alshehri. (2023) Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Ying Wang, Qiushuang Gao, Peng Yao, Qizheng Yao & Ji Zhang. (2023) Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-24.
Read now
Rofida Albash, Maha H. Ragaie, Mahmoud A. El Hassab, Radwan El-Haggar, Wagdy M. Eldehna, Sara T. Al-Rashood & Shaimaa Mosallam. (2022) Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Delivery 29:1, pages 1100-1111.
Read now
Karim M. ElSawy, Fahad M. Alminderej & Leo S. D. Caves. (2022) Disruption of 3CLpro protease self-association by short peptides as a potential route to broad spectrum coronavirus inhibitors. Journal of Biomolecular Structure and Dynamics 40:24, pages 13901-13911.
Read now
Armiya Sultan, Rafat Ali, Romana Ishrat & Sher Ali. (2022) Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19. Journal of Biomolecular Structure and Dynamics 40:23, pages 12848-12862.
Read now
Ismail Daoud, Fouzia Mesli, Nadjib Melkemi, Said Ghalem & Toufik Salah. (2022) Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping evaluation and dynamics simulation. Journal of Biomolecular Structure and Dynamics 40:23, pages 12574-12591.
Read now
Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla, Prateek Pathak, Vladislav Naumovich, Maria Grishina & Vladimir Potemkin. (2022) Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking. Journal of Biomolecular Structure and Dynamics 40:19, pages 9347-9360.
Read now
Vinicius S. Nunes, Diego F. S. Paschoal, Luiz Antônio S. Costa & Hélio F. Dos Santos. (2022) Antivirals virtual screening to SARS-CoV-2 non-structural proteins. Journal of Biomolecular Structure and Dynamics 40:19, pages 8989-9003.
Read now
Kateryna V. Miroshnychenko & Anna V. Shestopalova. (2022) Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. Journal of Biomolecular Structure and Dynamics 40:19, pages 8672-8686.
Read now
Mustafa Tekpinar & Ahmet Yildirim. (2022) Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases. Journal of Biomolecular Structure and Dynamics 40:14, pages 6243-6254.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2022) Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves. Journal of Biomolecular Structure and Dynamics 40:6, pages 2647-2662.
Read now
Mahmoud A. El Hassab, Tamer M. Ibrahim, Sara T. Al-Rashood, Amal Alharbi, Razan O. Eskandrani & Wagdy M. Eldehna. (2021) In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 727-736.
Read now
Oussama Abchir, Hassan Nour, Ossama Daoui, Imane Yamari, Souad ElKhattabi, Mhammed El Kouali, Mohammed Talbi, Abdelkbir Errougui & Samir Chtita. Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates for the SARS-CoV-2 inhibitors. Natural Product Research 0:0, pages 1-8.
Read now
Nahlah Makki Almansour. Identification of promising inhibitors against breast cancer disease by targeting NUDIX hydrolase 5 (NUDT5) biomolecule. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now

Articles from other publishers (50)

Rajarshi Roy, Md Fulbabu Sk, Omprakash Tanwar & Parimal Kar. (2022) Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease. Molecular Diversity 27:4, pages 1587-1602.
Crossref
Nimisha Ghosh, Indrajit Saha & Anna Gambin. (2023) Interactome-Based Machine Learning Predicts Potential Therapeutics for COVID-19. ACS Omega 8:15, pages 13840-13854.
Crossref
Vitor Martins de Freitas Amorim, Robson Francisco de Souza, Cristiane Rodrigues Guzzo & Anacleto Silva de Souza. (2023) Molecular Dynamics Simulations Suggest SARS-CoV-2 3CLpro Mutations in Beta and Omicron Variants Do Not Alter Binding Affinities for Cleavage Sites of Non-Structural Proteins. COVID 3:4, pages 622-636.
Crossref
Leila Ouni & Ali Ramazani. (2023) In Silico Screening of Some Anti-Cancer Drugs Against the Main Protease of COVID-19 Using Molecular Docking. Letters in Organic Chemistry 20:1, pages 77-90.
Crossref
Mubarak A. Alamri, Muhammad Tahir ul Qamar, Alhumaidi B. Alabbas, Safar M. Alqahtani, Manal A. Alossaimi, Sikandar Azam, Muhammad Harris Hashmi & Muhammad Shahid Riaz Rajoka. (2022) Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug–Protein Binding. Molecules 27:19, pages 6475.
Crossref
Jurica Novak & Vladimir A. Potemkin. (2022) A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study. Molecular Diversity 26:5, pages 2631-2645.
Crossref
Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi & Mohammad Hossein Asgarshamsi. (2022) The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects. Biophysical Chemistry 288, pages 106824.
Crossref
Paul Andrei Negru, Denisa Claudia Miculas, Tapan Behl, Alexa Florina Bungau, Ruxandra-Cristina Marin & Simona Gabriela Bungau. (2022) Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses. Biomedicine & Pharmacotherapy 153, pages 113432.
Crossref
Manuel I. Osorio, Osvaldo Yáñez, Mauricio Gallardo, Matías Zuñiga-Bustos, Jorge Mulia-Rodríguez, Roberto López-Rendón, Olimpo García-Beltrán, Fernando González-Nilo & José M. Pérez-Donoso. (2022) Search for Novel Potent Inhibitors of the SARS-CoV-2 Papain-like Enzyme: A Computational Biochemistry Approach. Pharmaceuticals 15:8, pages 986.
Crossref
Ziad Tareq Naman, Salim Kadhim, Zahraa J. K. Al-Isawi, Christopher J. Butch & Ziyad Tariq Muhseen. (2022) Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System. Pharmaceuticals 15:6, pages 741.
Crossref
Mohamed Fadlalla, Mazin Ahmed, Musab Ali, Abdulrhman A. Elshiekh & Bashir A. Yousef. (2022) Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models. Current Pharmacology Reports 8:3, pages 212-226.
Crossref
Mubarak A. Alamri, Muhammad Usman Mirza, Muhammad Muzammal Adeel, Usman Ali Ashfaq, Muhammad Tahir ul Qamar, Farah Shahid, Sajjad Ahmad, Eid A. Alatawi, Ghadah M. Albalawi, Khaled S. Allemailem & Ahmad Almatroudi. (2022) Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors. Pharmaceuticals 15:6, pages 659.
Crossref
Shabnam Ghahremanian, Mohammad Mehdi Rashidi, Kimai Raeisi & Davood Toghraie. (2022) Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. Journal of Molecular Liquids 354, pages 118901.
Crossref
Morteza Sadeghi & Mehran Miroliaei. (2022) Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study. In Silico Pharmacology 10:1.
Crossref
Nilanjan Adhikari, Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh & Tarun Jha. (2022) Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences. Journal of Molecular Structure 1251, pages 132041.
Crossref
Abdulrahim R. Hakami. (2022) Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach. Biology 11:2, pages 258.
Crossref
Ryan S. Ramos, Rosivaldo S. Borges, João S. N. de Souza, Inana F. Araujo, Mariana H. Chaves & Cleydson B. R. Santos. (2022) Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2. International Journal of Molecular Sciences 23:3, pages 1781.
Crossref
Qiaoming Liu, Jun Wan & Guohua Wang. (2022) A survey on computational methods in discovering protein inhibitors of SARS-CoV-2. Briefings in Bioinformatics 23:1.
Crossref
Jinyoung Byun & Juyong Lee. (2021) Identifying the Hot Spot Residues of the SARS-CoV-2 Main Protease Using MM-PBSA and Multiple Force Fields. Life 12:1, pages 54.
Crossref
Lianxiang Luo, Ai Zhong, Qu Wang & Tongyu Zheng. (2021) Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products. Marine Drugs 20:1, pages 29.
Crossref
Aqel Albutti. (2021) Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches. International Journal of Environmental Research and Public Health 19:1, pages 112.
Crossref
Amir Hossein Arshia, Shayan Shadravan, Aida Solhjoo, Amirhossein Sakhteman & Ashkan Sami. (2021) De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations. Computers in Biology and Medicine 139, pages 104967.
Crossref
Wenzhu Zhao, Ge Xu, Zhipeng Yu, Jianrong Li & Jingbo Liu. (2021) Identification of nut protein-derived peptides against SARS-CoV-2 spike protein and main protease. Computers in Biology and Medicine 138, pages 104937.
Crossref
Merve Yuce, Erdem Cicek, Tugce Inan, Aslihan Basak Dag, Ozge Kurkcuoglu & Fethiye Aylin Sungur. (2021) Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease . Proteins: Structure, Function, and Bioinformatics 89:11, pages 1425-1441.
Crossref
Rai C. Silva, Humberto F. Freitas, Joaquín M. Campos, Njogu M. Kimani, Carlos H. T. P. Silva, Rosivaldo S. Borges, Samuel S. R. Pita & Cleydson B. R. Santos. (2021) Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences 22:21, pages 11739.
Crossref
Iqra Muneer, Sajjad Ahmad, Anam Naz, Sumra Wajid Abbasi, Adel Alblihy, Abdulaziz A. Aloliqi, Faris F. Aba Alkhayl, Faris Alrumaihi, Sarfraz Ahmad, Youness El Bakri & Muhammad Tahir Ul Qamar. (2021) Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation. Frontiers in Molecular Biosciences 8.
Crossref
Sarfraz Ahmad, Muhammad Usman Mirza, Lee Yean Kee, Mamoona Nazir, Noorsaadah Abdul Rahman, John F. Trant & Iskandar Abdullah. (2021) Fragment‐based in silico design of SARS‐CoV‐2 main protease inhibitors . Chemical Biology & Drug Design 98:4, pages 604-619.
Crossref
Yusuf Muhammed, Abduljalal Yusuf Nadabo, Mkpouto Pius, Bashiru Sani, Jafar Usman, Nasir Anka Garba, Jaafaru Mohammed Sani, Basit Opeyemi Olayanju, Sunday Zeal Bala, Musa Garba Abdullahi & Misbahu Sambo. (2021) SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review. Biosafety and Health 3:5, pages 249-263.
Crossref
Abhik Paul, Arnab Sarkar, Sanjukta Saha, Avik Maji, Pritha Janah & Tapan Kumar Maity. (2021) Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors. Bioorganic & Medicinal Chemistry 46, pages 116301.
Crossref
Karen A. Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez, Andrea Galli, Anna Offersgaard, Rui Costa, Long V. Pham, Ulrik Fahnøe, Shan Feng, Troels K. H. Scheel, Santseharay Ramirez, Jens Bukh & Judith M. Gottwein. (2021) Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro . Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Majid Hassanzadeganroudsari, Amir Hossein Ahmadi, Niloufar Rashidi, Md Kamal Hossain, Amanda Habib & Vasso Apostolopoulos. (2021) Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 1:2, pages 111-128.
Crossref
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi & Zahra Najafimemar. (2021) Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery. Future Virology 16:6, pages 389-397.
Crossref
Vandana Solanki, Monalisa Tiwari & Vishvanath Tiwari. (2021) Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2. PeerJ 9, pages e11126.
Crossref
Chandra Bhushan Mishra, Preeti Pandey, Ravi Datta Sharma, Md Zubbair Malik, Raj Kumar Mongre, Andrew M Lynn, Rajendra Prasad, Raok Jeon & Amresh Prakash. (2021) Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach. Briefings in Bioinformatics 22:2, pages 1346-1360.
Crossref
Serena Dotolo, Anna Marabotti, Angelo Facchiano & Roberto Tagliaferri. (2021) A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics 22:2, pages 726-741.
Crossref
Riddhidev Banerjee, Lalith Perera & L.M. Viranga Tillekeratne. (2021) Potential SARS-CoV-2 main protease inhibitors. Drug Discovery Today 26:3, pages 804-816.
Crossref
Iqra Mehmood, Munazza Ijaz, Sajjad Ahmad, Temoor Ahmed, Amna Bari, Asma Abro, Khaled S. Allemailem, Ahmad Almatroudi & Muhammad Tahir ul Qamar. (2021) SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development. International Journal of Environmental Research and Public Health 18:4, pages 1626.
Crossref
Abhijit Chhetri, Sailesh Chettri, Pranesh Rai, Dipu Kumar Mishra, Biswajit Sinha & Dhiraj Brahman. (2021) Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (Mpro: 6LU7). Journal of Molecular Structure 1225, pages 129230.
Crossref
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad & Guanglin Li. (2021) Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 26:3, pages 674.
Crossref
Nikhil Pathak, Yun-Ti Chen, Yen-Chao Hsu, Nung-Yu Hsu, Chih-Jung Kuo, Hui Ping Tsai, Jaw-Jou Kang, Chih-Heng Huang, Sui-Yuan Chang, Yu-Hsiu Chang, Po-Huang Liang & Jinn-Moon Yang. (2020) Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing. ACS Nano 15:1, pages 857-872.
Crossref
Gihanna Galindez, Julian Matschinske, Tim Daniel Rose, Sepideh Sadegh, Marisol Salgado-Albarrán, Julian Späth, Jan Baumbach & Josch Konstantin Pauling. (2021) Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies. Nature Computational Science 1:1, pages 33-41.
Crossref
Abhijit Chhetri, Sailesh Chettri, Pranesh Rai, Biswajit Sinha & Dhiraj Brahman. (2021) Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (Mpro): A computational study. Journal of Molecular Structure 1224, pages 129178.
Crossref
Krishnaprasad Baby, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak & Yogendra Nayak. (2021) Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study. Archives of Medical Research 52:1, pages 38-47.
Crossref
Sohini Chakraborti, Sneha Bheemireddy & Narayanaswamy Srinivasan. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 163 177 .
Muhammad Tahir ul Qamar, Farah Shahid, Sadia Aslam, Usman Ali Ashfaq, Sidra Aslam, Israr Fatima, Muhammad Mazhar Fareed, Ali Zohaib & Ling-Ling Chen. (2020) Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infectious Diseases of Poverty 9:1.
Crossref
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M.H. Al-Hasani, Muhammad Tahir ul Qamar & Guanglin Li. (2020) Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach. Journal of Molecular Liquids 320, pages 114493.
Crossref
Mubarak A. Alamri, Muhammad Tahir ul Qamar, Muhammad Usman Mirza, Safar M. Alqahtani, Matheus Froeyen & Ling-Ling Chen. (2020) Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches. Journal of Pharmaceutical Analysis 10:6, pages 546-559.
Crossref
Kuppuswamy Kavitha, Subramaniam Sivakumar & Balasubramanian Ramesh. (2020) 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Biophysical Chemistry 267, pages 106478.
Crossref
Mahmoud A. El Hassab, Aly A. Shoun, Sara T. Al-Rashood, Tarfah Al-Warhi & Wagdy M. Eldehna. (2020) Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations. Frontiers in Chemistry 8.
Crossref
Olivier Sheik Amamuddy, Gennady M. Verkhivker & Özlem Tastan Bishop. (2020) Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 M pro . Journal of Chemical Information and Modeling 60:10, pages 5080-5102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.